PATENT CLAIM ANALYSIS

Application Number: 15873483
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "093200"]

Abstract:
A composition for treating a lysogenic virus, including a lentiviral vector encoding isolated nucleic acid encoding two or more gene editors chosen from gene editors that target viral DNA, gene editors that target viral RNA, and combinations thereof. A composition for treating a lytic virus, including a lentiviral vector encoding isolated nucleic acid encoding at least one gene editor that targets viral DNA and a viral RNA targeting composition. A composition for treating both lysogenic and lytic viruses, including a lentiviral vector encoding isolated nucleic acid encoding two or more gene editors that target viral RNA. A composition for treating lytic viruses. Methods of treating a lysogenic virus or a lytic virus, by administering the above compositions to an individual having a virus and inactivating the virus.

Claim (Index 28):
The method of  claim 27 , wherein the gene editors that target viral DNA are chosen from the group consisting of CRISPR-associated nucleases and Argonaute endonuclease gDNAs.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 2.65385
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15864309', '14838057', '14725943', '15148261', '15119867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7899692055237488
- 35 USC 102 Novelty (BERT): 0.5383487213636279
- Combined Prediction Score: 0.7648071571077368
- Mean Citation Score: 332.7666559999999
- Max Citation Score: 394.61044
- Similarity Product: 270.13840406164167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test